Bank of America’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-10
| Closed | – | – | 9007 |
|
|
2021
Q4 | $0 | Buy |
+10
| New | +$102 | ﹤0.01% | 8864 |
|
|
2021
Q3 | – | Sell |
-2
| Closed | – | – | 8539 |
|
|
2021
Q2 | $0 | Buy |
+2
| New | +$37 | ﹤0.01% | 8256 |
|
|
2020
Q3 | – | Sell |
-3
| Closed | – | – | 7295 |
|
|
2020
Q2 | $0 | Sell |
3
-1
| -25% | -$16 | ﹤0.01% | 7239 |
|
|
2020
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 7386 |
|
|
2019
Q4 | $0 | Hold |
4
| – | – | ﹤0.01% | 7534 |
|
|
2019
Q3 | $0 | Hold |
4
| – | – | ﹤0.01% | 7609 |
|
|
2019
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 7505 |
|
|
2019
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 7510 |
|
|
2018
Q4 | $0 | Hold |
4
| – | – | ﹤0.01% | 7480 |
|
|
2018
Q3 | $1K | Hold |
4
| – | – | ﹤0.01% | 7175 |
|
|
2018
Q2 | $1K | Hold |
4
| – | – | ﹤0.01% | 7009 |
|
|
2018
Q1 | $1K | Hold |
4
| – | – | ﹤0.01% | 7007 |
|
|
2017
Q4 | $1K | Hold |
4
| – | – | ﹤0.01% | 6952 |
|
|
2017
Q3 | $2K | Hold |
4
| – | – | ﹤0.01% | 6882 |
|
|
2017
Q2 | $2K | Buy |
+4
| New | +$2.34K | ﹤0.01% | 6767 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 7323 |
|
|
2016
Q4 | – | Sell |
-68
| Closed | -$15.5K | – | 7422 |
|
|
2016
Q3 | $18K | Buy |
68
+64
| +1,600% | +$19.6K | ﹤0.01% | 6179 |
|
|
2016
Q2 | $1K | Buy |
+4
| New | +$1.41K | ﹤0.01% | 7030 |
|
|
2016
Q1 | – | Sell |
-1
| Closed | -$374 | – | 7424 |
|
|
2015
Q4 | $0 | Sell |
1
-7
| -88% | -$5.06K | ﹤0.01% | 7529 |
|
|
2015
Q3 | $9K | Hold |
8
| – | – | ﹤0.01% | 6606 |
|
|
2015
Q2 | $13K | Buy |
8
+1
| +14% | +$1.55K | ﹤0.01% | 6503 |
|
|
2015
Q1 | $8K | Hold |
7
| – | – | ﹤0.01% | 6384 |
|
|
2014
Q4 | $7K | Hold |
7
| – | – | ﹤0.01% | 7184 |
|
|
2014
Q3 | $9K | Buy |
7
+3
| +75% | +$4.3K | ﹤0.01% | 7373 |
|
|
2014
Q2 | $7K | Buy |
4
+3
| +300% | +$5.71K | ﹤0.01% | 7585 |
|
|
2014
Q1 | $3K | Hold |
1
| – | – | ﹤0.01% | 7484 |
|
|
2013
Q4 | $3K | Hold |
1
| – | – | ﹤0.01% | 7586 |
|
|
2013
Q3 | $2K | Buy |
+1
| New | +$1.71K | ﹤0.01% | 7648 |
|
Other funds holding VYNT
FWM
JSC
Bank of America's VYNT Position: Q1 2022 in Review
Bank of America sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q1 2022, closing a stake of 10 shares.
Bank of America first reported a position in VYNT in Q3 2013 and held it in 27 quarters. The position peaked at $18K in Q3 2016. 23 funds tracked by Wall St. Rank hold VYNT as of Q1 2022.
- Bank of America reported no remaining Vyant Bio, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
- Bank of America sold 10 Vyant Bio, Inc. Common Stock shares in Q1 2022.
- Bank of America first reported a position in Vyant Bio, Inc. Common Stock in Q3 2013 and held it in 27 quarters.
- Bank of America's Vyant Bio, Inc. Common Stock position peaked at $18K in Q3 2016.
- 23 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q1 2022.
Based on Bank of America's 13F filing for Q1 2022, filed 16 May 2022.